Journal Mobile Options
Table of Contents
Vol. 214, No. 1, 2007
Issue release date: December 2006
Dermatology 2007;214:25–31

Multiple Large Solar Lentigos on the Upper Back as Clinical Markers of Past Severe Sunburn: A Case-Control Study

Derancourt C. · Bourdon-Lanoy E. · Grob J.-J. · Guillaume J.-C. · Bernard P. · Bastuji-Garin S.
aDepartment of Dermatology, Hôpital Robert-Debré, Université de Reims, Reims, bDepartment of Public Health, Hôpital Henri-Mondor, AP-HP, Paris 12 University, Créteil, cDepartment of Dermatology, Hôpital Sainte-Marguerite, AP-HM, Université de la Méditerranée, Marseille, and dDepartment of Dermatology, Hôpital Pasteur, Colmar, France

Individual Users: Register with Karger Login Information

Please create your User ID & Password

Contact Information

I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in


Background: Multiple solar lentigos commonly seen on the upper back and shoulders of adults are classically considered as a sign of photodamage, although epidemiological studies are scarce. Aim: To assess whether these lesions are clinical markers of past severe sunburn. Methods: A case-control study in two outpatient dermatology clinics in French university hospitals. Past episodes of moderate and severe sunburn were compared between 145 adult patients with multiple solar lentigos on the upper back and 145 matched controls. Results: In multivariate analysis adjusted for potential confounders, recalled episodes of sunburn during childhood, adolescence and adulthood were independently associated with the presence of multiple solar lentigos (adjusted odds ratios, 95% confidence intervals: 2.3 (1.1–5.2) and 28.1 (10.4–75.6) for moderate and severe sunburn, respectively). Conclusion: Multiple solar lentigos on the upper back and shoulders of adults are potential clinical markers of past severe sunburn which may thus be used to identify a population at higher risk of developing cutaneous malignant melanoma.

Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.


  1. IARC monographs on the evaluation of carcinogenic risks to humans: solar and ultraviolet radiation. IARC Monogr Eval Carcinog Risks Hum 1992;55:1–316.

    External Resources

  2. Gandini S, Sera F, Cattaruzza MS, Pasquini P, Piconni O, Boyle P, Melchi C: Meta-analysis of risk factors for cutaneous melanoma. II. Sun exposure. Eur J Cancer 2005;41:45–60.
  3. Diepgen TL, Mahler V: The epidemiology of skin cancer. Br J Dermatol 2002;146:1–6.
  4. Whiteman DC, Whiteman CA, Green AC: Childhood sun exposure as a risk factor for melanoma: a systematic review of epidemiologic studies. Cancer Causes Control 2001;12:69–82.
  5. Pfahlberg A, Kölmel KF, Gefeller O: Timing of extensive ultra-violet radiation and melanoma: epidemiology does not support the existence of a critical period of high susceptibility to solar ultra-violet radiation-induced melanoma. Br J Dermatol 2001;144:471–475.
  6. Tsao H, Atkins MB, Sober AJ: Management of cutaneous melanoma. N Engl J Med 2004;351:998–1021.
  7. Wilson PD, Kligman AM: Experimental induction of freckles by ultraviolet-B. Br J Dermatol 1982;106:401–406.
  8. Elder D, Elenitsas R: Benign pigmented lesions and malignant melanoma; in Elder D, et al (eds): Lever’s Histopathology of the Skin, ed 8. Philadelphia, Lippincott-Raven, 1997, pp 625–633.
  9. Rhodes AR: Neoplasms: benign neoplasias, hyperplasias and dysplasias of melanocytes; in Fitzpatrick TB, et al. (eds): Dermatology in General Medicine, ed 3. New York, McGraw-Hill, 1987, pp 877–946.
  10. Bastiaens M, Hoefnagel J, Westendorp R, et al: Solar lentigines are strongly related to sun exposure in contrast to ephelides. Pigment Cell Res 2004;17:225–229.
  11. Garbe C, Buttner P, Weiss J, et al: Associated factors in the prevalence of more than 50 melanocytic nevi, atypical melanocytic nevi and actinic lentigines: multicenter case-control study of the Central Malignant Melanoma Registry of the German Dermatological Society. J Invest Dermatol 1994;102:700–705.
  12. Fitzpatrick TB: The validity and practibility of sun reactive skin types I through VI. Arch Dermatol 1988;124:869–871.
  13. Azizi E, Lusky A, Kuskelevsky AP, Schewach-Millet M: Skin type, hair color and freckles are predictors of decreased minimal erythema ultraviolet-radiation dose. J Am Acad Dermatol 1988;19:32–38.
  14. Sackett DL: Bias in analytic research. J Chron Dis 1979;32:51–63.
  15. Naldi L, Imberti GL, Parazzini F, et al: Pigmentary traits, modalities of sun reaction, history of sunburns, and melanocytic nevi as risk factors for cutaneous malignant melanoma in the Italian population. Cancer 2000;88:2703–2710.
  16. Gandini S, Sera F, Cattaruzza MS, Pasquini P, Zanetti R, Masini C, Boyle P, Melchi C: Meta-analysis of risk factors for cutaneous melanoma. III. Family history, actinic damage and phenotypic factors. Eur J Cancer 2005;41:2040—2059.
  17. Gandini S, Sera F, Cattaruzza MS, Pasquini P, Abeni D, Boyle P, et al: Meta-analysis of risk factors for cutaneous melanoma. I. Common and atypical naevi. Eur J Cancer 2005;41:28–44.
  18. MacKie RM, Freudenberger T, Aitchison TC: Personal risk-factor chart for cutaneous melanoma. Lancet 1989;2:487–490.

Pay-per-View Options
Direct payment This item at the regular price: USD 38.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50